Literature DB >> 26643341

Is a New Standard Needed for Diffusion Methods for In Vitro Susceptibility Testing of Fosfomycin against Pseudomonas aeruginosa?

María Díez-Aguilar1, Laura Martínez-García2, Rafael Cantón3, María Isabel Morosini1.   

Abstract

We analyzed fosfomycin susceptibility results in Pseudomonas aeruginosa clinical isolates obtained by MIC gradient strips and disk diffusion methods using two different inocula, 10(8) and 10(6) CFU/ml, and compared them to the agar dilution reference method. Essential and categorical agreements were 93.6% and 95%, respectively, for the 10(6) CFU/ml alternative inoculum, and they were 67.6% and 78.2%, respectively, for the standard inoculum (10(8) CFU/ml). The use of the 10(6) CFU/ml inoculum improves the agreement values and inhibition zone readings.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26643341      PMCID: PMC4750655          DOI: 10.1128/AAC.02237-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Structure of fosfomycin resistance protein FosA from transposon Tn2921.

Authors:  Svetlana Pakhomova; Chris L Rife; Richard N Armstrong; Marcia E Newcomer
Journal:  Protein Sci       Date:  2004-04-09       Impact factor: 6.725

2.  Evaluation of the Bauer-Kirby-Sherris-Turck single-disc diffusion method of antibiotic susceptibility testing.

Authors:  J M Matsen; M J Koepcke; P G Quie
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Evaluation of 4 swab transport systems for the recovery of ATCC and clinical strains with characterized resistance mechanisms.

Authors:  María-Isabel Morosini; Elena Loza; Olga Gutiérrez; Felisa Almaraz; Fernando Baquero; Rafael Cantón
Journal:  Diagn Microbiol Infect Dis       Date:  2006-07-05       Impact factor: 2.803

5.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

6.  Fosfomycin: interpretation of inhibition zones obtained with the Bauer-Kirby agar disk diffusion susceptibility test.

Authors:  W H Traub; M Spohr
Journal:  Chemotherapy       Date:  1983       Impact factor: 2.544

7.  Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.

Authors:  María García-Castillo; Rosa Del Campo; María Isabel Morosini; Elena Riera; Gabriel Cabot; Rob Willems; Rosa van Mansfeld; Antonio Oliver; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

8.  The action of fosfomycin on the growth of Pseudomonas aeruginosa.

Authors:  C Hardisson; J Llaneza
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

Review 9.  Fosfomycin: use beyond urinary tract and gastrointestinal infections.

Authors:  Matthew E Falagas; Konstantina P Giannopoulou; George N Kokolakis; Petros I Rafailidis
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

10.  The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa.

Authors:  Alfredo Castañeda-García; Alexandro Rodríguez-Rojas; Javier R Guelfo; Jesús Blázquez
Journal:  J Bacteriol       Date:  2009-09-04       Impact factor: 3.490

View more
  1 in total

1.  Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model.

Authors:  Iain J Abbott; Elke van Gorp; Kelly L Wyres; Steven C Wallis; Jason A Roberts; Joseph Meletiadis; Anton Y Peleg
Journal:  J Antimicrob Chemother       Date:  2022-04-27       Impact factor: 5.758

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.